VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 457 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $23,121,191 | +37.6% | 681,438 | +28.3% | 0.09% | +38.5% |
Q1 2024 | $16,798,916 | -7.1% | 531,275 | -8.9% | 0.06% | +35.4% |
Q4 2023 | $18,086,893 | +69.3% | 583,260 | +46.9% | 0.05% | +33.3% |
Q3 2023 | $10,682,005 | -26.7% | 396,953 | -18.0% | 0.04% | -23.4% |
Q2 2023 | $14,570,952 | -2.2% | 483,924 | +5.1% | 0.05% | -13.0% |
Q1 2023 | $14,899,828 | +45.7% | 460,582 | +8.7% | 0.05% | +170.0% |
Q3 2022 | $10,224,000 | -52.0% | 423,890 | -45.6% | 0.02% | -39.4% |
Q2 2022 | $21,316,000 | -41.2% | 778,535 | -17.6% | 0.03% | -8.3% |
Q1 2022 | $36,247,000 | +257.1% | 945,161 | +174.4% | 0.04% | +227.3% |
Q3 2021 | $10,151,000 | -53.6% | 344,441 | -46.5% | 0.01% | -57.7% |
Q2 2021 | $21,871,000 | +1.0% | 643,640 | -3.4% | 0.03% | -18.8% |
Q1 2021 | $21,648,000 | -35.4% | 666,097 | -28.4% | 0.03% | -44.8% |
Q4 2020 | $33,502,000 | +31.9% | 930,094 | +34.3% | 0.06% | -50.4% |
Q2 2020 | $25,394,000 | +1571.8% | 692,321 | +949.9% | 0.12% | +875.0% |
Q1 2020 | $1,519,000 | -88.6% | 65,942 | -85.5% | 0.01% | -86.8% |
Q4 2019 | $13,306,000 | +154.6% | 454,425 | +95.0% | 0.09% | +56.9% |
Q1 2019 | $5,226,000 | +101.8% | 233,086 | +89.8% | 0.06% | +163.6% |
Q4 2018 | $2,590,000 | -30.7% | 122,795 | -39.2% | 0.02% | -26.7% |
Q3 2018 | $3,739,000 | -34.3% | 201,884 | -20.8% | 0.03% | -38.8% |
Q2 2018 | $5,687,000 | +9.0% | 254,896 | +7.4% | 0.05% | -5.8% |
Q1 2018 | $5,216,000 | -58.6% | 237,315 | -56.3% | 0.05% | -41.6% |
Q4 2017 | $12,614,000 | -20.2% | 542,769 | -21.1% | 0.09% | -37.8% |
Q3 2017 | $15,798,000 | -8.2% | 688,049 | -11.7% | 0.14% | -20.1% |
Q2 2017 | $17,204,000 | -13.4% | 779,188 | -10.5% | 0.18% | -22.5% |
Q1 2017 | $19,867,000 | -44.4% | 870,981 | -49.0% | 0.23% | -33.4% |
Q4 2016 | $35,732,000 | +4.6% | 1,708,017 | +32.1% | 0.35% | -6.5% |
Q3 2016 | $34,172,000 | +144.3% | 1,292,920 | +156.0% | 0.37% | +123.5% |
Q2 2016 | $13,990,000 | – | 505,069 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |